Physician profile
Kellie A Motschmann
NPI 1033425210
$2,061.11
in general payments reported to CMS, 2019-2025
26 companies · $39.09 in 2025
The $39.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $252 · 2021: $400 · 2022: $554 · 2025: $39.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $467.41 | 2019-2022 | |
| Therapeuticsmd, INC. | $270.17 | 2019-2022 | |
| Exeltis, USA INC. | $177.07 | 2019-2022 | |
| Pfizer INC. | $166.92 | 2019-2022 | |
| Myovant Sciences INC. | $135.44 | 2021-2022 | |
| Agile Therapeutics, INC. | $87.71 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $81.88 | 2022 | |
| Mylan Pharmaceuticals INC. | $81.33 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $74.88 | 2019-2020 | |
| Duchesnay USA Incorporated | $60.74 | 2019 | |
| Lupin INC. | $56.92 | 2019 | |
| Millicent US INC | $48.43 | 2019 | |
| Allergan, INC. | $39.86 | 2019 | |
| Urovant Sciences INC | $39.51 | 2022 | |
| Astellas Pharma US INC | $39.12 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $39.09 | 2025 | Arista |
| Avion Pharmaceuticals | $26.47 | 2019-2020 | |
| Aspira Women'S Health INC | $26.22 | 2019 | |
| Evofem Biosciences, INC. | $24.49 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.18 | 2021 | |
| Scynexis, INC. | $19.69 | 2022 | |
| Organon LLC | $17.28 | 2022 | |
| Vertical Pharmaceuticals, LLC | $16.58 | 2019 | |
| Merck Sharp & Dohme LLC | $15.09 | 2019 | |
| Roche Diagnostics Corporation | $14.84 | 2019 | |
| Daiichi Sankyo INC. | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Motschmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.